Mylan Laboratories Inc. won a preliminary ruling in a patent dispute, clearing the way for approval of its generic version of Bristol-Myers Squibb Co.’s anti-anxiety drug BuSpar. U.S. District Judge ...

Watson Pharmaceuticals on Wednesday renewed its legal effort to launch a generic version of Bristol-Myers Squibb’s popular anti-anxiety drug, BuSpar. In a suit filed in U.S. District Court for the ...

In the case of co-administration of erythromycin, itraconazole and nefazodone with Buspar, it price of buspar recommended price of buspar reduce the dose of the tranquilizer not to cause side effects.

Consumers who requested refunds from being overcharged for the anti-anxiety drug called BuSpar will get an average of $800 in the mail this week. A settlement made last year between 38 states and ...

A coalition of consumer groups filed state and federal lawsuits Friday against Bristol-Myers Squibb Co., alleging that the New York-based drug company used illegal means to maintain its exclusive ...